Mary E Schramm
Biographic Data
| ID | 9697494 |
|---|---|
| NAME | Mary E Schramm |
| GIVEN NAMES | Mary E |
| FAMILY NAME | Schramm |
| SIGNATURE | SCHRAMM M E |
| AFFILIATIONS | Quinnipiac University |
| ORCID | 0000-0002-6017-3937 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Framing the strategic R&D paradigm shift in Big Pharma
Purpose Between 1985 and 2000, the six largest US pharmaceutical firms entered a very active period of partnerships with other pharmaceutical firms to expand their knowledge of biotechnology-based research and development (R&D) frameworks and to bolster the growth of their drug portfolios. The purpose of this study is to examine the annual reports published by these companies for evidence of strategic framing of these partnerships. Design/methodo…
No prominent works on this page.
Framing the strategic R&D paradigm shift in Big Pharma
Purpose Between 1985 and 2000, the six largest US pharmaceutical firms entered a very active period of partnerships with other pharmaceutical firms to expand their knowledge of biotechnology-based research and development (R&D) frameworks and to bolster the growth of their drug portfolios. The purpose of this study is to examine the annual reports published by these companies for evidence of strategic framing of these partnerships. Design/methodo…
Biotechnology and Related Fields (1 works) · Business (1 works) · Content analysis (1 works) · Economics (1 works) · Engineering (1 works) · Innovation and Knowledge Management (1 works) · Management (1 works) · Marketing (1 works) · Originality (1 works) · Pharmaceutical Economics and Policy (1 works)